Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Cheng, Hui Fang ^a   Wang, Jun Ling ^a   Vinson, Gavin P ^b   Harris, Raymond C ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Kidney; L 3,4 dihydroxyphenylalamine; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVODOPA; MESSENGER RNA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; KIDNEY PROXIMAL TUBULE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031939767     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.1.f10     Document Type: Article

References (61)

1. Ader, J.-L., T. Tran-Van, and F. Praddaude. Reduced urinary kallikrein activity in rats developing spontaneous hypertension. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F964-F969, 1987.
2. Aperia, A. Dopamine action and metabolism in the kidney. Curr. Opin. Nephrol. Hypertens. 3: 39-45, 1994.
3. Arendshorst, W. J., C. Chatziantoniou, and F. H. Daniels. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int. 38: S92-S96, 1990.
4. Barker, S., W. Marchant, M. M. Ho, J. R. Puddefoot, J. P. Hinson, A. J. L. Clark, and G. P. Vinson. A monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian target tissues. J. Mol. Endocrinol. 11: 241-245, 1993.
5. Beierwaltes, W. H., W. J. Arrendshorst, and R. F. Klemmer. Electrolyte balance in young spontaneously hypertensive rats. Hypertension 4: 908-915, 1982.
6. Bradshaw, B., and T. J. Moore. Abnormal regulation of adrenal angiotensin II receptors in spontaneously hypertensive rats. Hypertension 11: 49-54, 1988.
7. Braam, B., K. D. Mitchel, J. Fox, and L. G. Navar. Proximal tubular secretion of angiotensin II in rats. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F891-F898, 1993.
8. Burns, K. D., T. Homma and R. C Harris. The intrarenal renin-angiotensin system. Semin. Nephrol. 13: 13-30, 1993.
9. Burns, K. D., T. Inagami, and R. C. Harris. Cloning of a rabbit kidney cortex AT1 angiotensin II receptor that is present in proximal tubule epithelium. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F645-F654, 1993.
10. Capponi, A. M., and K. J. Catt. Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling. J. Biol. Chem. 255: 12081-12086, 1980.
11. Chatziantoniou, C., and W. J. Arendshorst. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F853-F862, 1993.
12. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sci. USA 92: 2924-2928, 1995.
13. Chen, C., R. E. Beach, and M. F. Lokhandwala. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372, 1993.
14. Chen, C. J., S. Apparsundarum, and M. F. Lokhandwala. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J. Pharmacol. Exp. Ther. 256: 486-491, 1991.
15. Chen, C. J., and M. F. Lokhandwala. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14: 615-628, 1992.
16. Cheng, H.-F., B. N. Becker, K. D. Burns, and R. C. Harris. Angiotensin II regulates its receptor sites in rabbit proximal tubule. J. Clin. Invest. 95: 2012-2019, 1995.
17. Cheng, H.-F., B. N. Becker, and R. C. Harris. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 97: 2745-2752, 1996.
18. Cheng, H.-F., K. D. Burns, and R. C. Harris. Reduced proximal tubule angiotensin II receptor expression in experiment diabetes mellitus. Kidney Int. 46: 1603-1610, 1994.
19. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
20. Cogan, M. G. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458, 1990.
21. Correa, F. M., M. Viswanathan, G. M. Ciuffo, K. Tsutsumi, and J. M. Saavedra. Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides 16: 19-24, 1995.
22. Dilley, J. R., and W. J. Arendshorst. Enhanced tubuloglomerular feedback activity in rats developing spontaneous hypertension. Am. J. Physiol. 247 (Renal Fluid Electrolyte Physiol. 16): F672-F679, 1984.
23. Dilley, J. R., C. T. Stier, Jr., and W. J. Arendshorst. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am. J. Physiol. 246 (Renal Fluid Electrolyte Physiol. 15): F12-F20, 1984.
24. Felder, R. A., S. Kinoshita, A. Sidhu, K. Ohbu and F. J. Kaskel. A renal dopamine-1 defect in two genetic models of hypertension. Am. J. Hypertens. 3: 96S-99S, 1990.
25. + exchanger. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F514-F521, 1990.
26. + exchanger in spontaneously hypertensive rats. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F526-F536, 1991.
27. Haddad, G., and R. Garcia. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR. J. Mol. Cell. Cardiol. 28: 351-361, 1996.
28. Harrap, S. B., and A. E. Doyle. Renal haemodynamics and total body sodium in immature spontaneously hypertensive and Wistar-Kyoto rats. J. Hypertens. 4, Suppl. 3: S249-S252, 1986.
29. Harrap, S. B., J. A. Nicolaci, and A. E. Doyle. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin. Exp. Pharmacol. Physiol. 13: 753-765, 1986.
30. Harris, R. C., and T. O. Daniel. Epidermal growth factor binding, stimulation of phosphorylation and inhibition of gluconeogenesis in rat proximal tubule. J. Cell. Physiol. 139: 383-391, 1989.
31. Haws, R. M., P. W. Shaul, B. S., Arant, Jr., B. A. Atiyeh, and M. G. Seikaly. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats. Pediatr. Res. 35: 671-676, 1994.
32. Ingelfinger, J. R., W. Min Zuo, E. A. Fon, K. E. Ellison and V. J. Dzau. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J. Clin. Invest. 85: 417-423, 1990.
33. Iwai, N., and T. Inagami. Identification of a candidate gene responsible for the high blood pressure of spontaneously hypertensive rats. J. Hypertens. 10: 1155-1157, 1992.
34. Kinoshita, S., A. Sidhu, and R. A. Felder. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J. Clin. Invest. 84: 1849-1856, 1989.
35. Levine, D. Z., M. Iacovitti, S. Buckman, and K. D. Burns. Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J. Clin. Invest. 97: 120-125, 1996.
36. Li, P., and E. K. Jackson. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 251: 909-921, 1989.
37. Madeddu, P.,V. Anania, M. V. Varoni, P. P. Parpaglia, M. P. Dementis, M. C. Fattaccio, D. Palomba, D. Pollock, and N. Glorioso. Prevention by blockade of angiotensin subtype 1-receptors of the development of genetic hypertension but not its heritability. Br. J. Pharmacol. 115: 557-562, 1995.
38. Makita, N., N. Iwai, T. Inagami, and K. F. Badr. Two distinct pathways in the down-regulation of type-I angiotensin II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 185: 142-146, 1992.
39. Matsushima, Y., M. Kawamura, and S. Akabane. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J. Hypertens. 6: 791-796, 1988.
40. Morton, J. J., E. C. Beattie, and F. Macpherson. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J. Vasc. Res. 29: 264-269, 1992.
41. Ohbu, K., and R. A. Felder. Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F274-F279, 1993.
42. Paglin, S., and J. D. Jamieson. Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes. Proc. Natl. Acad. Sci. USA 79: 3739-3743, 1982.
43. 1 receptor. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F989-F995, 1993.
44. Pfister, J., D. Felix, and H. Imboden. Immunohistochemical demonstration of angiotensin II receptors in rat brain by use of an anti-idiotypic antibody. Regul. Pept. 44: 109-117, 1993.
45. Racz, K., O. Kuchel, and N. T. Buu. Bromocriptine decreases blood pressure of spontaneously hypertensive rats without affecting the adrenomedullary synthesis of catecholamines. J. Cardiovasc. Pharmacol. 8: 676-680, 1986.
46. Schuster, V. L., J. P. Kokko, and H. R. Jacobson. Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J. Clin. Invest. 73: 507-515, 1984.
47. Seikaly, M. G., B. S. Arant, Jr., and F. D. Seney, Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments in the rat. J. Clin. Invest. 86: 1352-1357, 1990.
48. Sidhu, A., P. Vachvanischsanong, P. A. Jose, and R. A. Felder. Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats. J. Clin. Invest. 89: 789-793, 1992.
49. Stier, C. T., Jr., H. D. Istkovitz, and Y. H. Chen. Urinary dopamine and sodium excretion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 15: 105-123, 1993.
50. Thomas, D., P. J. Harris, and T. O. Morgan. Altered responsiveness of proximal tubule fluid reabsorption of peritubular angiotensin II in spontaneously hypertensive rats. J. Hypertens. 8: 407-410, 1990.
51. Thomas, D., P. J. Harris, and T. O. Morgan. Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rats. J. Hypertens. 6: S449-S451, 1988.
52. Vyas, S. J., and E. K. Jackson. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J. Pharmacol. Exp. Ther. 273: 768-777, 1995.
53. Vinay, P., A. Gougoux, and G. Lemieux. Isolation of a pure suspension of rat proximal tubules. Am. J. Physiol. 241 (Renal Fluid Electrolyte Physiol. 10): F403-F411, 1981.
54. Vinson, G. P., J. R. Puddefoot, M. M. Ho, S. Barker, J. Mehta, E. Saridogan, and O. Djahanbakhch. Type 1 angiotensin II receptors in rat and human sperm. J. Endocrinol. 144: 369-378, 1995.
55. Weiner, I. D., A, R. New, A. E. Milton, and C. C. Tisher. Regulation of luminal alkalinization and acidification in the cortical collecting duct by angiotensin II. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F730-F738, 1995.
56. Wood, J. M., C. R. Schnell, and N. R. Levens. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 21: 1056-1061, 1993.
57. Wu, J. N., D. Edwards, and K. H. Berecek. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril. Hypertension 23: 819-822, 1994.
58. Xie, M.-H., F.-Y. Liu, P. C. Wong, P. B. M. W. H. Timmermans, and M. G. Cogan. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II antagonist. Kidney Int. 38: 473-479, 1990.
59. Yamano, Y., K. Ohyama, S. Chaki, D. Guo, and T. Inagami. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. Biochem. Biophys. Res. Commun. 187: 1426-1433, 1992.
60. Yoshimura, M., S. Kambara, H. Okabayashi, H. Takahashi, and H. Ijichi. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clin. Exp. Hypertens. A9: 1141-1157, 1987.
61. Zelezna, B., E. M. Richards, W. Tang, D. Lu, C. Sumners, and M. K. Raizada. Characterization of a polyclonal anti-peptide antibody to the angiotensin II type-1 (AT1) receptor. Biochem. Biophys. Res. Commun. 183: 781-788, 1992.